市场调查报告书
商品编码
1593526
药品合约包装市场规模、份额和成长分析(按类型、包装材料和地区):产业预测(2024-2031)Pharmaceutical Contract Packaging Market Size, Share, Growth Analysis, By Type (Primary Packaging, Secondary Packaging), By Material (Plastics & Polymers, Paper & Paperboard), By Region - Industry Forecast 2024-2031 |
2022年全球药品合约包装市场规模为56.5亿美元,从2023年的61.1亿美元扩大到2031年的109.1亿美元,在预测期内(2024-2031年)预计复合年增长率为7.51。百分比)。
在新兴市场对合约包装公司的需求不断增长以及製药行业的外包趋势的推动下,高品质化学包装市场预计将显着成长。製药公司越来越多地将合约包装服务作为降低製造成本的策略,特别是考虑到许多小型製药公司面临的挑战,例如内部包装材料、专业知识和财务资源的限制。为了有效克服这些限制,这些小型製药公司正在与合约包装组织 (CPO) 和契约製造组织 (CMO) 建立有益的伙伴关係。因为外包包装解决方案不仅提供了获得先进技术的机会,还可以让企业专注于其核心业务领域,简化包装流程,并提高服务效率。因此,CPO 和合约开发与製造组织 (CDMO) 日益成为寻求优化业务并确保在竞争环境中提供高品质包装解决方案的製药公司的首选。这种动态演进凸显了外包在提高药厂在市场上的能力和竞争力方面所发挥的重要作用。
Global Pharmaceutical Contract Packaging Market size was valued at USD 5.65 billion in 2022 and is poised to grow from USD 6.11 billion in 2023 to USD 10.91 billion by 2031, growing at a CAGR of 7.51% during the forecast period (2024-2031).
The market for high-quality chemical packaging is poised for significant growth, driven by rising demand from contract packers in emerging markets and a trend towards outsourcing within the pharmaceutical sector. Pharmaceutical companies are increasingly turning to contract packaging services as a strategy to lower manufacturing costs, particularly in the face of challenges such as limited in-house packaging materials, expertise, and financial resources that many small players encounter. These small pharmaceutical firms are forming beneficial partnerships with contract packaging organizations (CPOs) and contract manufacturing organizations (CMOs) to effectively navigate these constraints. The global expansion of the pharmaceutical industry further supports this trend, as outsourcing packaging solutions not only provides access to advanced technologies but also allows companies to focus on core business areas, streamline packaging processes, and enhance service efficiency. Consequently, CPOs and contract development and manufacturing organizations (CDMOs) are increasingly becoming the preferred choice for pharmaceutical companies seeking to optimize their operations and ensure high-quality packaging solutions amid a competitive landscape. This evolving dynamic underscores the vital role that outsourcing plays in elevating the capabilities and competitiveness of pharmaceutical manufacturers in the marketplace.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Contract Packaging Market Segmental Analysis
Global Pharmaceutical Contract Packaging Market is segmented by Type, Material, and region. Based on Type , the market is segmented into Primary Packaging (Bottles, Vials, Ampoules, Blister Packs, Others), Secondary Packaging, Tertiary Packaging. Based on Material, the market is segmented into Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market is significantly driven by the increasing trend of outsourcing among pharmaceutical companies. As these organizations confront complex packaging requirements, stringent regulatory standards, and cost-performance pressures, they increasingly turn to specialized contract packaging providers. This strategic shift allows pharmaceutical firms to focus on core activities such as drug development and marketing, while benefiting from the expertise of contract packaging companies that can deliver innovative, compliant, and efficient packaging solutions. Consequently, this outsourcing trend not only enhances operational efficiency but also fosters better resource allocation, making it a pivotal factor in the growth of the contract packaging market.
Restraints in the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market faces significant restraints due to the complexities of regulatory compliance that vary across different countries. Each region imposes distinct packaging and labeling guidelines, as well as stringent requirements for indestructible seals and durability warranties. The financial burden associated with meeting these diverse standards can be substantial, particularly for small- and medium-sized contract packaging firms that may lack the necessary resources. Moreover, the potential repercussions of non-compliance, such as product recalls or legal liabilities, further deter these companies from actively participating in the market, ultimately hindering overall market growth and innovation.
Market Trends of the Global Pharmaceutical Contract Packaging Market
The Global Pharmaceutical Contract Packaging market is witnessing a significant trend towards adopting sustainable packaging solutions, driven by heightened regulatory scrutiny and consumer demand for environmentally-friendly practices. Companies are increasingly prioritizing eco-conscious alternatives by integrating biodegradable plastics, recyclable materials, and minimizing bulky packaging. This shift is forcing packaging contract providers to invest in research and development initiatives aimed at creating innovative packaging products that align with stringent regulatory standards while also addressing sustainability goals. As governments enforce stricter environmental regulations and consumers champion greener initiatives, the emphasis on sustainable packaging is poised to grow, reshaping strategies within the pharmaceutical industry.